Vivo Capital
Vivo Capital, LLC is a private equity and venture capital firm founded in 1996 and headquartered in Palo Alto, California, with additional offices in Asia. The firm specializes in healthcare investments across various stages, including early stage, growth capital, and public equity. With approximately $5.8 billion in assets under management, Vivo has invested in over 290 public and private companies globally. Its focus lies primarily in biopharmaceuticals, specialty pharmaceuticals, medical devices, and healthcare services, targeting companies in the U.S. and East Asia, particularly China. Vivo aims to invest between $2 million and $40 million, typically favoring minority equity stakes. The firm's multi-disciplinary team includes professionals with backgrounds in medicine, science, and entrepreneurship, allowing it to effectively navigate the complexities of the healthcare sector.
Sinovac Biotech Ltd. is a biopharmaceutical company based in Beijing, China, specializing in the research, development, manufacture, and commercialization of vaccines for human infectious diseases. Its product portfolio includes vaccines for hepatitis A and B, seasonal influenza, H5N1 and H1N1 pandemic influenza, mumps, and enterovirus 71, among others. Key marketed products include Healive, a hepatitis A vaccine, Bilive, a combined hepatitis A and B vaccine, and Panflu.1, which was the first H1N1 vaccine approved globally. Sinovac also plays a significant role in government stockpiling programs for vaccines in China. The company is actively developing new vaccines, including those for pneumococcal disease and rubella, with various clinical trials underway. Sinovac collaborates with notable institutions such as GlaxoSmithKline and Tianjin CanSino Biotechnology to enhance its vaccine development efforts. Established in 1999, Sinovac primarily sells its products in China while also exporting selected vaccines to countries like Mongolia, Nepal, and the Philippines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.